Tiempo real estimado
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
38,44 USD | -0,85 % | -1,37 % | +3,99 % |
Resumen de negocios
Número de empleados: 373
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Enzymes and Devices
100,0
%
| 660 | 100,0 % | 829 | 100,0 % | +25,62 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
70,8
%
| 438 | 66,4 % | 587 | 70,8 % | +34,07 % |
Switzerland
18,0
%
| 167 | 25,3 % | 149 | 18,0 % | -10,68 % |
Belgium
7,0
%
| 2 | 0,3 % | 58 | 7,0 % | +2.694,73 % |
All Other Foreign
2,4
%
| 5 | 0,8 % | 20 | 2,4 % | +272,23 % |
Japan
1,8
%
| 48 | 7,3 % | 15 | 1,8 % | -68,51 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Helen Torley
CEO | Chief Executive Officer | 61 | 06/01/14 |
Nicole LaBrosse
DFI | Director of Finance/CFO | 41 | 01/01/15 |
Mark Snyder
CMP | Compliance Officer | 57 | 03/01/22 |
Steve Knowles
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/18 |
Michael LaBarre
CTO | Chief Tech/Sci/R&D Officer | 60 | 16/06/08 |
Tram Bui
IRC | Investor Relations Contact | - | 01/01/22 |
Amy Marinne Fox
HRO | Human Resources Officer | - | 01/01/20 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Connie Matsui
BRD | Director/Board Member | 70 | 31/07/06 |
Chairman | 59 | 05/08/15 | |
Barbara Duncan
BRD | Director/Board Member | 59 | 03/02/23 |
Helen Torley
CEO | Chief Executive Officer | 61 | 06/01/14 |
Matthew Posard
BRD | Director/Board Member | 56 | 28/03/13 |
Akiko Miyashita
BRD | Director/Board Member | 68 | 15/03/22 |
Director/Board Member | 65 | 10/09/18 | |
Nicole LaBrosse
DFI | Director of Finance/CFO | 41 | 01/01/15 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 127 054 240 | 125 682 266 ( 98,92 %) | 0 | 98,92 % |
Información de la empresa
Sector
Ventas por región
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
+4,63 % | 4925,9 M | |
-3,06 % | 102 mil M | |
+1,85 % | 96,29 mil M | |
+2,10 % | 22,18 mil M | |
-15,13 % | 21,2 mil M | |
-9,07 % | 18,31 mil M | |
-39,98 % | 17,38 mil M | |
-14,38 % | 16,36 mil M | |
+5,66 % | 13,97 mil M | |
+31,39 % | 12,17 mil M |
- Bolsa de valores
- Acciones
- Acción HALO
- Empresa Halozyme Therapeutics, Inc.